Unpredicted Aberrant Splicing Products Identified in Postmortem Sudden Cardiac Death Samples.
Ontology highlight
ABSTRACT: Molecular screening for pathogenic mutations in sudden cardiac death (SCD)-related genes is common practice for SCD cases. However, test results may lead to uncertainty because of the identification of variants of unknown significance (VUS) occurring in up to 70% of total identified variants due to a lack of experimental studies. Genetic variants affecting potential splice site variants are among the most difficult to interpret. The aim of this study was to examine rare intronic variants identified in the exonic flanking sequence to meet two main objectives: first, to validate that canonical intronic variants produce aberrant splicing; second, to determine whether rare intronic variants predicted as VUS may affect the splicing product. To achieve these objectives, 28 heart samples of cases
SUBMITTER: Coll M
PROVIDER: S-EPMC9604081 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA